NCT05047549

Brief Summary

In order to assess the burden of respiratory syncytial virus on infant mortality in Pakistan, nasopharyngeal swab sampling and minimally invasive tissue sampling (MITS) will be conducted on deceased infants under 6 months of age. The specimens will be analysed by the microbiology and histopathology labs at Aga Khan University, Karachi, Pakistan. Verbal consent will be obtained from parents of deceased infants, and a cause of death lab report and grief counseling services will be offered to enrolled parents who gave consent for specimen collection. The study is funded by Bill \& Melinda Gates Foundation in affiliation with Research Triangle Institute (RTI) MITS Surveillance Alliance.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 2, 2020

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

November 23, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 17, 2021

Completed
Last Updated

September 17, 2021

Status Verified

September 1, 2021

Enrollment Period

10 months

First QC Date

November 23, 2020

Last Update Submit

September 12, 2021

Conditions

Keywords

respiratory syncytial virusinfant mortalityminimally invasive tissue sampling

Outcome Measures

Primary Outcomes (3)

  • RSV nasopharyngeal swab

    A special swab will be use to take a sample from the nose or throat and Reverse transcription-Polymerase chain reaction (RT-PCR) will be done to understand the burden of disease in deceased children under 6 months of age from a real time community setting.

    2 months

  • RSV lung/thorax microbiology

    lung fluid will be aspirated and Reverse transcription-Polymerase chain reaction (RT-PCR) will be done to assess the burden of RSV in deceased infants under 6 months of age.

    2 months

  • RSV lung/thorax histopathology

    Minimally invasive tissue sampling (MITS) will be performed to obtain lung tissue specimens Tissues will be examined through histopathology. Through the sample collection we will understand the burden of RSV among deceased infants, as well as cause of death due to upper respiratory tract infection.

    2 months

Eligibility Criteria

Age1 Minute - 6 Months
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Deceased neonates and infants (under 6 months of age) born and died within specified catchment areas

You may qualify if:

  • Parents, caregivers of deceased infants (under 6 months of age)
  • Residing in one of 2 catchment areas in Karachi, enrolled in Demographic Surveillance System
  • Have given informed verbal consent for collection of nasopharyngeal specimen AND lung/thorax tissue sampling

You may not qualify if:

  • Miscarriages (under 28 gestational weeks)
  • Known stillbirths
  • Guest/visiting families in the area that will not be participating in verbal autopsy after infant death

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aga Khan University

Karachi, Sindh, 74800, Pakistan

RECRUITING

MeSH Terms

Conditions

Infant DeathCommunity-Acquired Infections

Condition Hierarchy (Ancestors)

DeathPathologic ProcessesPathological Conditions, Signs and SymptomsInfections

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 23, 2020

First Posted

September 17, 2021

Study Start

November 2, 2020

Primary Completion

September 1, 2021

Study Completion

September 1, 2021

Last Updated

September 17, 2021

Record last verified: 2021-09

Locations